Inivata Offers Mobile Phlebotomy Services for patients undergoing InVisionFirst® Lung ctDNA liquid biopsy
May 12, 2020 07:00 ET
|
Inivata
Inivata Offers Mobile Phlebotomy Services for patients undergoing InVisionFirst® Lung ctDNA liquid biopsy Research Triangle Park, NC, USA May 12, 2020 – Inivata (www.inivata.com) a leader in...
Inivata Receives Medicare Final Coverage Decision for InVisionFirstTM-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer
March 05, 2019 07:00 ET
|
Inivata
Inivata Receives Medicare Final Coverage Decision for InVisionFirstTM-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer Final Coverage Supports the Use of InVisionFirst-Lung for Aiding...
Inivata to Present Results of Prospective Clinical Validation Study of its InVisionFirstTM-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer (NSCLC) at the World Conference on Lung Cancer
September 24, 2018 07:00 ET
|
Inivata
Inivata to Present Results of Prospective Clinical Validation Study of its InVisionFirstTM-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer (NSCLC) at theWorld Conference on Lung...
Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™-Lung Liquid Biopsy Test
September 13, 2018 13:07 ET
|
Inivata
Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™-Lung Liquid Biopsy Test Draft Coverage Supports the Use of InVisionFirst-Lung for Aiding...